Posted on June 15, 2023

June 15, 2023 – By Gina Shaw, Neurology Today The incidence of Parkinson’s disease (PD) in patients with essential tremor (ET) is significantly higher than that reported in historical population-based control groups across numerous countries, according to a prospective longitudinal study published online May 10 in Neurology: Clinical Practice. The findings are consistent with those of […]

Posted on June 14, 2023

June 14, 2023 – Cala announced today that it launched its next-generation Cala kIQ system, a wearable device that delivers therapy for neurological disorders. The San Mateo, California-based company develops the Cala Trio device for transcutaneous afferent patterned stimulation (TAPS) therapy. Cala designed the Trio device for treating tremor. Its kIQ system delivers therapy for action […]

Posted on June 14, 2023

By Tish Hevel, CEOBrain Donor Project If you’re interested in advancing the science of neurologic diseases and disorders, including essential tremor, here’s something you may want to consider: making arrangements now to donate your brain when you die. There is currently an urgent need for brain donation for a variety of neurological disorders. Breakthroughs in […]

Categories: ET Research
Posted on June 12, 2023

BOSTON, June 09, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the outcomes from a recent end-of-Phase 2 meeting with the U. S. Food and Drug Administration (FDA) […]